Malignant lipid cell tumor of the ovary: clinical, biochemical and etiologic considerations.
D015068:17-Ketosteroids / Q000097:blood; D006907:17-alpha-Hydroxypregnenolone / Q000097:blood; D000328:Adult; D000731:Androstanes / Q000097:blood; D000738:Androsterone / Q000652:urine; D002849:Chromatography, Gas; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D005965:Glucuronates / Q000652:urine; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000209:etiology / Q000652:urine; D011278:Pregnanes / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D018310:Sertoli-Leydig Cell Tumor / Q000209:etiology / Q000652:urine; D013431:Sulfates / Q000652:urine; D013739:Testosterone / Q000097:blood; D014770:Virilism
D015068:17-Ketosteroids; D000731:Androstanes; D005965:Glucuronates; D006908:Hydroxyprogesterones; D011278:Pregnanes; D013431:Sulfates; D011279:Pregnanetriol; D006907:17-alpha-Hydroxypregnenolone; D013739:Testosterone; D005043:Etiocholanolone; D000738:Androsterone